articleJournal of Clinical InvestigationJan 18, 2007BRONZE OA

Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma

University of Pennsylvania · Cancer Research Institute of the Slovak Academy of Sciences

PubMed
Indexed incrossrefdoajpubmed

Abstract

Autophagy is a lysosome-dependent degradative pathway frequently activated in tumor cells treated with chemotherapy or radiation. Whether autophagy observed in treated cancer cells represents a mechanism that allows tumor cells to survive therapy or a mechanism for initiating a nonapoptotic form of programmed cell death remains controversial. To address this issue, the role of autophagy in a Myc-induced model of lymphoma generated from cells derived from p53ER(TAM)/p53ER(TAM) mice (with ER denoting estrogen receptor) was examined. Such tumors are resistant to apoptosis due to a lack of nuclear p53. Systemic administration of tamoxifen led to p53 activation and tumor regression followed by tumor recurrence.…

Citation impact

1,123
total citations
FWCI
37.50
Percentile
100%
References
60
Citations per year

Authors

8

Topics & keywords

Keywords
  • Autophagy
  • ATG5
  • Apoptosis
  • Cancer research
  • Programmed cell death
  • Lysosome
  • Small hairpin RNA
  • Cancer cell
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.